Mark Ma
Impact in
- Orthopedics and Sports Medicine top 10%
- Bone health and osteoporosis research
-
- Iron Metabolism and Disorders
Papers in
-
- Biosimilars and Bioanalytical Methods 5
- Co-authors
- Juan José Pérez Ruixo (2 shared papers)Graham R. Jang (1 shared paper)Sameer Doshi (1 shared paper)Andrew T. Chow (1 shared paper)Liviawati Sutjandra (1 shared paper)Mark J. Rose (2 shared papers)Mark C. Peterson (1 shared paper)Yuling Wu (1 shared paper)
- Journals
- Bioanalysis (3 papers)The AAPS Journal (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)Journal of Medicinal Chemistry (1 paper)Pharmaceutical Research (1 paper)
- Partner nations
- United StatesSwitzerlandSpain
In The Last Decade
Mark Ma
16 papers receiving 338 citations
Peers
Comparison fields: 5 of 50
- Orthopedics and Sports Medicine 36
- Hematology 44
- Immunology 59
- Radiology, Nuclear Medicine and Imaging 60
- Endocrinology, Diabetes and Metabolism 34
Countries citing papers authored by Mark Ma
This map shows the geographic impact of Mark Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ma more than expected).
Fields of papers citing papers by Mark Ma
This network shows the impact of papers produced by Mark Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ma. The network helps show where Mark Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 101 | |
| 2 | 2008 | 76 | |
| 3 | 2010 | 71 | |
| 4 | 2007 | 35 | |
| 5 | 2022 | 22 | |
| 6 | 2019 | 12 | |
| 7 | 2017 | 9 | |
| 8 | 2018 | 9 | |
| 9 | 2018 | 6 | |
| 10 | 2019 | 6 | |
| 11 | 2010 | 5 | |
| 12 | 2014 | 5 | |
| 13 | 2003 | 2 | |
| 14 | Exploratory biomarkers in the HGF/SF:c-Met axis: preclinical and clinical results | 2008 | 2 |
| 15 | 2025 | 2 | |
| 16 | 2015 | 1 |
About Mark Ma
Mark Ma is a scholar working on Immunology, Pharmacology, Geriatrics and Gerontology, Radiology, Nuclear Medicine and Imaging and Virology, having authored 16 papers that have together received 364 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (5 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Analytical Methods in Pharmaceuticals (1 paper), RNA and protein synthesis mechanisms (1 paper), Bone health and osteoporosis research (1 paper), Lysosomal Storage Disorders Research (1 paper), Liver physiology and pathology (1 paper) and RNA Research and Splicing (1 paper). The work is most often cited by research in Orthopedics and Sports Medicine (36 citations), Hematology (44 citations), Immunology (59 citations), Radiology, Nuclear Medicine and Imaging (60 citations) and Endocrinology, Diabetes and Metabolism (34 citations). Mark Ma has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include Juan José Pérez Ruixo, Graham R. Jang, Sameer Doshi, Andrew T. Chow, Liviawati Sutjandra, Mark J. Rose, Mark C. Peterson, Yuling Wu, Jim J. Xiao and Hongyan Li. Their work appears in journals such as Bioanalysis, The AAPS Journal, Cancer Chemotherapy and Pharmacology, Journal of Medicinal Chemistry and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.